HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Nov. 3, 2020 (HealthDay News) -- Pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have increased risks for severe COVID-19-associated illness, according to research published in the Nov. 2 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Laura D. Zambrano, Ph.D., from the CDC COVID-19 Response Team, and colleagues provide updated information about symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2.
The CDC received reports for 1,300,938 women aged 15 to 44 years with laboratory results indicative of acute infection with SARS-CoV-2. The researchers found that for 35.5 percent of women with laboratory-confirmed infection, data on pregnancy status were available, and 88.7 percent were symptomatic. Among symptomatic women, 5.7 percent were reported to be pregnant. Pregnant women were significantly more likely to be admitted to an intensive care unit, receive invasive ventilation, receive extracorporeal membrane oxygenation, and die compared with nonpregnant women after adjustment for age, race, and underlying medical conditions (adjusted risk ratios, 3.0, 2.9, 2.4, and 1.7, respectively). Disparities in risk by subgroup were highlighted on stratification by age and race/ethnicity.
"Understanding the risk posed by SARS-CoV-2 infection in pregnant women can inform clinical practice, risk communication, and medical countermeasure allocation," the authors write. "Pregnant women should be informed of their risk for severe COVID-19-associated illness and the warning signs of severe COVID-19."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 25, 2022